
Celsus is an AI company specializing in medical imaging analysis. Their solutions aim to improve the quality and accuracy of diagnoses by assisting healthcare professionals. The company offers AI-powered services for mammography, fluorography, chest CT, and brain CT scans. These services help detect pathologies, analyze images according to international standards, and minimize human error. Celsus integrates with existing hospital systems via API, web, or desktop installations, and directly with equipment. They have processed over 4 million studies and have a history of awards and certifications, including CE Mark and registration as a medical device. Their mission is to help doctors help patients by making disease recognition and treatment more effective.

Celsus is an AI company specializing in medical imaging analysis. Their solutions aim to improve the quality and accuracy of diagnoses by assisting healthcare professionals. The company offers AI-powered services for mammography, fluorography, chest CT, and brain CT scans. These services help detect pathologies, analyze images according to international standards, and minimize human error. Celsus integrates with existing hospital systems via API, web, or desktop installations, and directly with equipment. They have processed over 4 million studies and have a history of awards and certifications, including CE Mark and registration as a medical device. Their mission is to help doctors help patients by making disease recognition and treatment more effective.
Sector: AI medical imaging / radiology decision support
Founded: 2017
Key products: AI analysis for mammography, fluorography/chest X‑ray, chest CT, brain CT
Regulatory status: Russian medical device registration (risk class 3) and CE mark
Scale: Processed >4 million studies; ~15 employees (reported)
Notable investor: NTI Venture Fund (180M RUB, Dec 2020)
Improving diagnostic accuracy and workflow efficiency in radiology through automated image analysis and decision support.
2017
Healthtech / Medical imaging AI
180000000.00
Investment reported as 180 million rubles in December 2020
“Has backing from NTI Venture Fund and mentions of additional investors including Mail.ru Cloud Solutions (records indicate three investors)”